Core Scientific (CORZ) Total Liabilities (2020 - 2026)

Core Scientific has disclosed Total Liabilities across 7 years of filings, most recently posting $4.4 billion for Q1 2026.

• Total Liabilities for Q1 2026 came in at $4.4 billion, up 142.14% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.4 billion (up 142.14% YoY), and the FY2025 annual result was $3.3 billion, up 36.85% from the prior year.
• Total Liabilities came in at $4.4 billion for Q1 2026 at Core Scientific, up from $3.3 billion in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $4.4 billion in Q1 2026 to a low of $1.1 billion in Q3 2023.
• The 5-year median for Total Liabilities is $1.6 billion (2022), against an average of $2.0 billion.
• Across the five-year window, Total Liabilities soared 5198.54% in 2022 and retreated 26.62% in 2023, its largest moves.
• Core Scientific's Total Liabilities stood at $1.2 billion in 2022, then increased by 7.56% to $1.3 billion in 2023, then soared by 84.78% to $2.4 billion in 2024, then surged by 36.85% to $3.3 billion in 2025, then soared by 32.17% to $4.4 billion in 2026.
• The last three Total Liabilities figures came in at $4.4 billion (Q1 2026), $3.3 billion (Q4 2025), and $3.4 billion (Q3 2025), per Business Quant data.